Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005/CSEM009)

计划入组 60 人 · 首次发布于 2015 年 12 月 8 日

Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients

计划入组 65 人 · 首次发布于 2021 年 6 月 10 日

Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer

首次发布于 2016 年 1 月 11 日

Taxane

1,4-Dioxane

C₄H₈O₂

Hexane-1,6-Diol

C₆H₁₄O₂

Teoxane SA

Switzerland

ROXANE LABORATORIES INC

United States

Boehringer Ingelheim Roxane, Inc.

United States

FDA Approves RHA Redensity Eye for Undereye Hollowing in Adults 22 and Older

FDA Approves RHA Dynamic Volume for Midface Contour Enhancement in Adults

Anthracycline-Based Chemotherapy Improves Survival in High-Risk, Early-Stage Breast Cancer